The ALS functional ratings scale-revised clinical outcome assessment remote-use equivalency study.
Ended Awarded Last action
- Contract number
- 75F40122F19026
- Awardee
-
Research Triangle Institute UEI JJHCMK4NT5N3
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $2,067,808
Award facts
- Opportunity
-
- FDARFCOPOC2022113226 Solicitation number
- Contract value 100% obligated
- $2,067,808.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541611 Administrative Management and General Management Consulting Services
- PSC
- B599 Special Studies/Analysis- Other
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Time and Materials
- Place of performance
- Durham, NC 27709, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $80,000 | |
| Supplemental Agreement for work within scope | $114,000 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Original award | $1,873,808 |
About this award
The Food and Drug Administration awarded a BPA call contract valued at $2.07M to Research Triangle Institute (RTI International) for the ALS Functional Ratings Scale-Revised Clinical Outcome Assessment Remote-Use Equivalency Study. Conducted on a time and materials basis, this research initiative is being performed at RTI's headquarters in Research Triangle Park, North Carolina. The study examines the equivalency of remote-use administration for the ALS Functional Ratings Scale-Revised, a critical clinical outcome assessment tool used in amyotrophic lateral sclerosis research and clinical trials. This work supports the FDA's regulatory science mission by generating evidence on the validity and reliability of alternative assessment methodologies, which can inform guidance for clinical trial design and patient outcome measurement in neurodegenerative disease research.
This contract award represents a task order call under RTI International's existing $70M FDA Blanket Purchase Agreement for Quick Turnaround Social Science Research Services, which operates through December 2030. RTI International, a prominent nonprofit research organization established in 2001, regularly executes contracts across multiple federal agencies including NIH, CDC, CMS, and EPA, bringing extensive expertise in health services research, clinical evaluation, and evidence synthesis. The contract carries no set-aside designation, reflecting open competition. With a contract completion date of February 28, 2025, the study is anticipated to deliver findings that advance FDA's understanding of remote clinical outcome assessment methodologies in neurodegenerative disease contexts.
Quick answers
Who was awarded contract 75F40122F19026?
75F40122F19026 was awarded to Research Triangle Institute by Food and Drug Administration (Department of Health and Human Services) on September 16, 2022.
How much is contract 75F40122F19026 worth?
The government has obligated $2,067,808 on 75F40122F19026.
Is contract 75F40122F19026 an order under another contract?
Yes. 75F40122F19026 is a BPA call under GS00F354CA-75F40120A00017, a blanket purchase agreement, on Multiple Award Schedule (MAS).
Was contract 75F40122F19026 competed?
The extent of competition for 75F40122F19026 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award